is hims semaglutide fda approved Novo Nordisk calls out dangers of compounded GLP-1s in new ad What is compounded semaglutide and
Description
Accessed June 6, 2023
People treated with the drug tend to be less hungry, have fewer cravings and feel more satiated after eating than those not on the drug all factors that may translate to weight loss
Tirzepatides are a class of Glucagon-like Peptide-1 receptor agonists and is one of the GLP-1/GIP medications that are used for Diabetes and Weight Loss
This isn't a factor of obesity either
Remember to be patient and adaptable as your health demands and lifestyle change
